[Experimental clinical study of the effectiveness of glycopeptide in gastroduodenal pathology].
D000284:Administration, Oral; D004341:Drug Evaluation; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006020:Glycopeptides / Q000627:therapeutic use*; D006595:Hexosamines / Q000627:therapeutic use*; D006601:Hexoses / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009438:Neuraminic Acids / Q000627:therapeutic use*; D010437:Peptic Ulcer / Q000188:drug therapy*
D005765:Gastrointestinal Agents; D006020:Glycopeptides; D006595:Hexosamines; D006601:Hexoses; D009438:Neuraminic Acids
Estudio clínico experimental de la efectividad del sulfoglicopéptido en patología gastroduodenal